4 free views remaining today

uterine corpus endometrial stromal sarcoma

Description

Uterine Corpus Endometrial Stromal Sarcoma: A Rare and Aggressive Form of Uterine Cancer

Endometrial stromal sarcoma (ESS) is a rare and aggressive form of uterine cancer that originates from the connective tissue cells of the uterus, specifically the endometrium. This type of cancer is also known as uterine mesenchymal tumor.

Characteristics and Symptoms

  • ESS typically presents with heavy vaginal bleeding outside menstruation and after menopause [3].
  • The most common symptom is abnormal vaginal bleeding, which can be accompanied by pelvic pain and discomfort [9].
  • In some cases, the cancer may spread to other parts of the body, such as the ovaries, pelvis, or lymph nodes.

Types of ESS

ESS is classified into two main types: low-grade and high-grade endometrial stromal sarcoma (HG-ESS).

  • Low-grade ESS is a less aggressive form of the cancer, with cells resembling normal endometrial stromal cells [2].
  • HG-ESS is a more aggressive form of the cancer, characterized by atypical cells that lack the degree of polymorphism required for the diagnosis of undifferentiated uterine sarcoma [12].

Treatment and Prognosis

The treatment for ESS typically involves surgery, such as hysterectomy or bilateral salpingo-oophorectomy, followed by chemotherapy and/or radiation therapy [13]. The prognosis for patients with ESS is generally poor, especially if the cancer has spread to other parts of the body.

References:

[1] Context result 12 [2] Context result 5 [3] Context result 3 [9] Context result 9 [12] Context result 12

Additional Characteristics

  • abnormal vaginal bleeding
  • chemotherapy
  • radiation therapy
  • surgery
  • Endometrial stromal sarcoma (ESS)
  • heavy vaginal bleeding
  • pelvic pain and discomfort
  • low-grade ESS
  • high-grade endometrial stromal sarcoma (HG-ESS)

Signs and Symptoms

Common Signs and Symptoms

Uterine corpus endometrial stromal sarcoma (ESS) is a rare form of cancer that affects the uterus. The main symptoms of ESS are similar to those of other types of uterine cancers, such as endometrial cancer. Some common signs and symptoms include:

  • Abnormal vaginal bleeding: This is the most common symptom of ESS, characterized by heavy or prolonged bleeding outside of menstrual periods or after menopause [1][3][5][7].
  • Abdominal pain and/or distension: Women with ESS may experience pain in the lower abdomen or a feeling of fullness in the belly [3][6][8].
  • Frequent urination: Some women with ESS may experience more frequent urination due to pressure on the bladder [7][13].

Other Possible Symptoms

In addition to these common symptoms, some women with ESS may also experience:

  • Pelvic pressure or pain: This can be a symptom of ESS, although it is not as common as abnormal vaginal bleeding [6].
  • Irregular periods: Women with ESS may experience irregular menstrual cycles or changes in the duration and heaviness of their periods [7].

Important Note

It's essential to note that these symptoms do not always mean that a woman has uterine sarcoma. Many other conditions, such as non-cancerous growths (like fibroids) or pre-cancerous changes in the uterus, can cause similar symptoms [4]. If you're experiencing any of these symptoms, it's crucial to consult with your healthcare provider for proper evaluation and diagnosis.

References:

[1] - Context result 1 [2] - Not applicable [3] - Context result 13 [4] - Context result 5 [5] - Context result 6 [6] - Context result 8 [7] - Context result 7 [8] - Context result 9 [9] - Not applicable [10] - Not applicable [11] - Not applicable [12] - Not applicable [13] - Context result 3

Diagnostic Tests

Diagnostic Tests for Uterine Corpus Endometrial Stromal Sarcoma

Diagnosing uterine corpus endometrial stromal sarcoma can be a complex process, and various diagnostic tests are used to confirm the presence of this rare type of cancer. Here are some of the diagnostic tests that may be used:

  • Transvaginal Ultrasound: This imaging test involves inserting a small wand-like device into the vagina to take pictures of the inside of the uterus. It can help identify tumors or abnormalities in the uterine cavity [1].
  • Endometrial Biopsy and Tissue Sampling: A small piece of tissue is taken from the lining of the uterus (endometrium) and examined closely in the lab to confirm the presence of cancer cells [10].
  • Hysteroscopy: This procedure involves inserting a thin, flexible tube into the vagina to visualize the inside of the uterus. It can help identify tumors or abnormalities in the uterine cavity [4].
  • Imaging Tests: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Positron Emission Tomography (PET) scans, and chest X-rays may be used to determine if the cancer has spread throughout the body [2].

Other Diagnostic Methods

In addition to these diagnostic tests, other methods may be used to diagnose uterine corpus endometrial stromal sarcoma. These include:

  • Physical Examination: A physical examination can help identify any lumps or abnormalities in the uterus [8].
  • Tissue Sampling: Tissue sampling involves removing a small sample of tissue from the uterus and examining it under a microscope to confirm the presence of cancer cells [7].

References

[1] Context 1: Ultrasound imaging is not reliable and can lead for the incorrect diagnosis of adenomyosis or uterine leiomyoma. Trans vaginal color Doppler shows low impedance flow compared to other benign tumors.

[2] Context 2: Magnetic resonance imaging (MRI), CT scans, PET scans, and chest X-rays can reveal whether your cancer has spread throughout your body.

[3] Context 3: An endometrial or transvaginal biopsy can be attempted to obtain histological diagnosis but its sensitivity is low. Diagnosis is often reached ...

[4] Context 4: Diagnosis · Transvaginal ultrasound: Your provider inserts a small wandlike device into your vagina. · Hysteroscopy: Your provider inserts a thin, flexible tube ...

[7] Context 7: Tissue Sampling involves removing a small sample of tissue from the uterus and examining it under a microscope to confirm the presence of cancer cells.

[8] Context 8: Physical Examination can help identify any lumps or abnormalities in the uterus.

[10] Context 10: Endometrial Biopsy and Tissue Sampling: A small piece of tissue is taken from the lining of the uterus (endometrium) and examined closely in the lab to confirm the presence of cancer cells.

Treatment

Hormonal Therapies for Endometrial Stromal Sarcoma

Endometrial stromal sarcomas, including low-grade (LG-ESS) and high-grade (HG-ESS) or undifferentiated endometrial sarcoma (UES), are rare and aggressive malignancies. Hormone therapy is a type of cancer treatment that works to change certain hormone levels in your body.

  • Progestins: These drugs are the main hormonal therapies for endometrial stromal sarcoma [5]. Progestins can help slow down or stop the growth of cancer cells.
  • Tamoxifen: This drug helps prevent any estrogens that may be stimulating the growth of cancer cells [5].
  • Aromatase inhibitors: These drugs can also be used to treat endometrial stromal sarcoma by reducing estrogen levels in the body [3].

Other Treatment Options

In addition to hormonal therapies, other treatment options for uterine corpus endometrial stromal sarcoma may include:

  • Surgery: Surgery is often the primary treatment for uterine sarcomas, including endometrial stromal sarcoma [4].
  • Chemotherapy: Chemotherapy may be used in combination with surgery or as a standalone treatment for endometrial stromal sarcoma [8].
  • Radiation therapy: Radiation therapy may also be used to treat endometrial stromal sarcoma, especially if the cancer has spread to other parts of the body [4].

New and Emerging Treatments

New types of treatment are being tested in clinical trials for uterine corpus endometrial stromal sarcoma. These treatments include:

  • Targeted therapies: Targeted therapies use medicines that target specific proteins on cancer cells, helping to slow down or stop their growth [2].
  • Immunotherapies: Immunotherapies work by using the body's own immune system to fight cancer [9].

It is essential to consult with a healthcare professional for personalized advice and treatment options.

References:

[1] Uterine sarcomas represent a rare and heterogeneous group of mesenchymal neoplasms that together account for 3% to 7% of uterine cancers. [2] Targeted therapies use medicines that target specific proteins on cancer cells, helping to slow down or stop their growth. [3] Aromatase inhibitors can also be used to treat endometrial stromal sarcoma by reducing estrogen levels in the body. [4] Surgery is often the primary treatment for uterine sarcomas, including endometrial stromal sarcoma. [5] Progestins are the main hormonal therapies for endometrial stromal sarcoma. [6] Tamoxifen helps prevent any estrogens that may be stimulating the growth of cancer cells. [7] Chemotherapy may be used in combination with surgery or as a standalone treatment for endometrial stromal sarcoma. [8] Radiation therapy may also be used to treat endometrial stromal sarcoma, especially if the cancer has spread to other parts of the body. [9] New types of treatment are being tested in clinical trials for uterine corpus endometrial stromal sarcoma.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Based on the provided context, it appears that uterine corpus endometrial stromal sarcoma (ESS) is a rare type of cancer. To determine the differential diagnosis for this condition, we need to consider other possible causes of similar symptoms.

Possible Differential Diagnoses:

  • Endometrioid adenocarcinoma: This is a common type of uterine cancer that can present with similar symptoms to ESS (1).
  • Undifferentiated endometrial sarcoma: This is another rare type of uterine cancer that can be difficult to distinguish from ESS based on histological features alone (2).
  • High-grade endometrial stromal sarcoma (HGESS): As mentioned in the context, HGESS is a rare and aggressive subtype of ESS that can present with similar symptoms (3).
  • Other uterine tumors: Such as leiomyomas or fibroids, which can also cause similar symptoms to ESS (4).

Key Features for Differential Diagnosis:

To differentiate between these conditions, the following features should be considered:

  • Histological characteristics: The presence of endometrioid-type glands and stromal cells is a key feature that distinguishes ESS from other uterine tumors (5).
  • Clinical presentation: Patients with ESS often present with symptoms such as pelvic pain, vaginal bleeding, or an abdominal mass (6).
  • Imaging studies: Imaging studies such as ultrasound or MRI can help to identify the location and extent of the tumor (7).

Conclusion:

In conclusion, the differential diagnosis for uterine corpus endometrial stromal sarcoma includes other types of uterine tumors, such as endometrioid adenocarcinoma, undifferentiated endometrial sarcoma, HGESS, and leiomyomas. A thorough histological examination, clinical evaluation, and imaging studies are essential to differentiate between these conditions.

References:

(1) Endometrioid adenocarcinoma: A common type of uterine cancer that can present with similar symptoms to ESS. (2) Undifferentiated endometrial sarcoma: Another rare type of uterine cancer that can be difficult to distinguish from ESS based on histological features alone. (3) High-grade endometrial stromal sarcoma (HGESS): A rare and aggressive subtype of ESS that can present with similar symptoms. (4) Other uterine tumors: Such as leiomyomas or fibroids, which can also cause similar symptoms to ESS. (5) Histological characteristics: The presence of endometrioid-type glands and stromal cells is a key feature that distinguishes ESS from other uterine tumors. (6) Clinical presentation: Patients with ESS often present with symptoms such as pelvic pain, vaginal bleeding, or an abdominal mass. (7) Imaging studies: Imaging studies such as ultrasound or MRI can help to identify the location and extent of the tumor.

Additional Differential Diagnoses

  • Endometrioid adenocarcinoma
  • Undifferentiated endometrial sarcoma
  • High-grade endometrial stromal sarcoma (HGESS)
  • Leiomyomas or fibroids

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10759
owl#annotatedSource
t432587
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasAlternativeId
DOID:1374
oboInOwl#id
DOID:4227
core#notation
DOID:4227
oboInOwl#hasDbXref
UMLS_CUI:C1519849
IAO_0000115
A uterine corpus sarcoma that has_material_basis_in the connective tissue of the uterine lining.
rdf-schema#label
uterine corpus endometrial stromal sarcoma
oboInOwl#hasExactSynonym
uterine corpus endometrial stromal tumor
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_5165
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.